# Incretin Effect on the Immunological Phenotype

> **NCT01782261** · PHASE2 · COMPLETED · sponsor: **Medical University of Graz** · enrollment: 15 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Saxagliptin

## Key facts

- **NCT ID:** NCT01782261
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01782261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01782261, "Incretin Effect on the Immunological Phenotype". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01782261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*